蒲公英是一个专注于制药技术的传播和GMP理论的实践的平台。该平台提供了丰富的资源和信息，包括专家视角、资源下载、悬赏答疑、有问有答、医药杂谈等，为从业人员提供了一个交流和学习的场所。此外，蒲公英还提供了关于生物制品、化学药品、中药产品、医疗器械等多个领域的信息和服务。
We're tracking 蒲公英's market expansion
How 蒲公英's international expansion compares to its competitors
蒲公英YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 蒲公英You | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
China's innovative drug industry has grown significantly from 2015 to 2025, with increased clinical trials, approvals, and global recognition.
iBIO hosted a medical device innovation event in Toronto, focusing on regulatory pathways, commercialization, and early-stage investment for innovative medical devices.
International Exosome Technologies & Research Institute (IERI) launched in Beijing on June 1, 2026, by multiple organizations to standardize China's exosome industry through research, standards development, and industry collaboration.
Be the first to find verified contacts at 蒲公英
Quick answers about 蒲公英's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
